MarketsStocksBROOKS
BR

Brooks Laboratories Ltd

NSE: BROOKSBSE: 533543Healthcare
Download Research Report7-page PDF
66.50
-0.40%
NSE · auto-updates while market open
Prev Close
₹132.91
Day High
₹68.80
Day Low
₹64.00
Mkt Cap
₹204 Cr
P / E
8.3
P / B
1.7
ROE
22.3%
52W High
₹164.02
52W Low
₹36.30
Key Metrics
Market Cap
₹204 Cr
P / E
8.30
P / B
1.66
EV / EBITDA
27.82
ROCE
5.7%
ROE
22.3%
Debt / Equity
0.06
Book Value
₹41.64
EPS
₹8.35
Div Yield
0.0%
Face Value
₹10
Promoter Holding
52.6%
Revenue · ₹ Cr
70
FY20
77
FY21
91
FY22
63
FY23
79
FY24
83
FY25
86
FY26
Net Profit · ₹ Cr
25
-24
-19
-19
-32
-20
-10
FY20FY21FY22FY23FY24FY25FY26
EPS · ₹ per share
₹6.3
₹8.3
₹-9.2
₹-13.8
₹-7.8
₹-12.6
₹-7.7
FY19FY20FY21FY22FY23FY24FY26
P / E Ratio · price ÷ TTM EPS
015631346911-10-13Jun 21Feb 23Oct 24Jun 26
P/E 8.0×Median 22.9×TTM EPS
Q1 2026 snapshot
Sales
₹21 Cr
Operating profit
-
OPM
-
Net profit
₹2 Cr
EPS
₹0.52
Scorecard · 7 axes
Quality
Avg
55/100
Valuation
Strong
8.3×
Growth
Bad
-12.6%
Profitability
Avg
14.0%
Performance
Bad
-51.8%
Entry Point
Strong
41%
Red Flags
Strong
0 flags
Shareholding Pattern
52.6%Promoter
Promoter52.6%
FII0.2%
DII10.4%
Public36.8%
Quarterly Results · ₹ Cr
QuarterFY24 12QFY25 03QFY25 06QFY25 09QFY25 12QFY26 03Q
Revenue20.51523.9425.7323.8416.6920.65
Net Profit-2.132-1.4589.5857.9775.4991.523
NPM %-10.4%-6.1%37.3%33.5%32.9%7.4%
AlertPre-trade